---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-037855"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T08:59:32.212081+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cara Therapeutics CMO Joana Goncalves resigns effective April 16, 2024

## Summary
- Dr. Joana Goncalves notified Company of resignation on March 19, 2024.
- Departure is to pursue another opportunity and not related to any disagreement.
- She will remain CMO through April 16, 2024, assisting in transition.
- Duties will be assumed by other senior management team members.

## SEC filing metadata
- accession: 0001104659-24-037855
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465924037855/0001104659-24-037855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465924037855/tm249486d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-037855
- JSON: https://secwatch.observer/filing/0001104659-24-037855.json
- Plain text: https://secwatch.observer/filing/0001104659-24-037855.txt

## Key facts
- Executive change
  Joana Goncalves resigned as Chief Medical Officer at Tvardi Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On March 19, 2024, Dr. Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc. (the “Company”), informed the Company of her intention to resign from her role effective April 16, 2024, to pursue another opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1346830/000110465924037855/0001104659-24-037855-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.